Prognostic Factors (Univariate Analysis)
| . | CR Rate (%) . | 4-yr DFS (%) . | 4-yr OS (%) . | |||
|---|---|---|---|---|---|---|
| FAB classification | ||||||
| M2-M3 | ||||||
| Others | 78 (N = 194) | P = .05 | 53 (N = 152) | P < .0001 | 46 (N = 199) | P < .0001 |
| 69 (N = 310) | 29 (N = 215) | 18 (N = 318) | ||||
| Initial WBC count | ||||||
| <30 × 109/L | ||||||
| ≥30 × 109/L | 78 (N = 321) | P = .0004 | 42 (N = 253) | P = .005 | 42 (N = 332) | P < .001 |
| 63 (N = 183) | 31 (N = 114) | 29 (N = 185) | ||||
| Karyotype | ||||||
| Favorable | ||||||
| Normal and intermediate | ||||||
| Unfavorable | ||||||
| Missing data | 87.5 (N = 48) | P = .003 | 59 (N = 42) | P = .02 | 61 (N = 48) | P = .018 |
| 76.5 (N = 226) | 32 (N = 173) | 38 (N = 226) | ||||
| 58 (N = 36) | 47 (N = 21) | 39 (N = 36) | ||||
| 67.5 (N = 194) | 40 (N = 131) | 39 (N = 207) |
| . | CR Rate (%) . | 4-yr DFS (%) . | 4-yr OS (%) . | |||
|---|---|---|---|---|---|---|
| FAB classification | ||||||
| M2-M3 | ||||||
| Others | 78 (N = 194) | P = .05 | 53 (N = 152) | P < .0001 | 46 (N = 199) | P < .0001 |
| 69 (N = 310) | 29 (N = 215) | 18 (N = 318) | ||||
| Initial WBC count | ||||||
| <30 × 109/L | ||||||
| ≥30 × 109/L | 78 (N = 321) | P = .0004 | 42 (N = 253) | P = .005 | 42 (N = 332) | P < .001 |
| 63 (N = 183) | 31 (N = 114) | 29 (N = 185) | ||||
| Karyotype | ||||||
| Favorable | ||||||
| Normal and intermediate | ||||||
| Unfavorable | ||||||
| Missing data | 87.5 (N = 48) | P = .003 | 59 (N = 42) | P = .02 | 61 (N = 48) | P = .018 |
| 76.5 (N = 226) | 32 (N = 173) | 38 (N = 226) | ||||
| 58 (N = 36) | 47 (N = 21) | 39 (N = 36) | ||||
| 67.5 (N = 194) | 40 (N = 131) | 39 (N = 207) |